Broker News

Swissquote Expects Annual Growth over 40%

Investors have been rushing to Swissquote’s trading platforms, as COVID-19 causes extreme market volatility. This was an announcement from the Swiss banking group in an update on Wednesday.

As seen across the industry, Swissquote said that the first months of 2020 saw a strong increase in trading activity. It also saw a massive inflow of new clients, driven by heightened volatility.

Consequently, the Swiss banking group has achieved a solid performance in the first half of this year. Its net revenues increased by more than 40 percent from the same period last year. 

Moreover, pre-tax profit is higher by more than 120 percent on a yearly comparison.

For the first half of the year, the company now estimates that net revenues will be more than CHF 160 million. This is compared to the CHF 112.2 million recorded in the first half of 2019.

PBT to Reach CHF 56M at Swissquote

This represents a significant increase in the overall performance of the Switzerland-based company. Net revenues for the Swiss bank in H1 of 2019 was lower by 0.5 percent against the previous year. It had net revenues of CHF 112.8 million.

On the other hand, pre-tax profit is forecast to exceed CHF 56 million. This is more than twice the CHF 25.1 million profit in the first half of last year. 

In H1 of 2019, operating revenues for the first half was CHF 117.2M. This was down by 0.7% from the CHF 118.0M net revenues achieved in the first half of 2018. 

Swissquote said that the outlook for 2020 reported on 17 March anticipated Net revenues and profitability to increase by 10%. A revised outlook taking into account a more cautious second half-year 2020 will be provided. This is part of the publication of the half-year results on 11 August 2020.

Share
Published by
John Marley

Recent Posts

  • Education

Cryptocurrency Taxation: A Comprehensive Guide

The evolution of digital finance has ushered in the era of cryptocurrencies, which the IRS… Read More

2 hours ago
  • Stock Markets

Summit Therapeutics Targets $3.73B Cap in Oncology Drive

Quick Look: Summit Therapeutics's key drug in advanced trials for lung cancer, leveraging dual pathway… Read More

3 hours ago
  • Commodities

Sugar Price Fluctuates 2.4% Amid Global Production Shifts

Quick Look: NY's Sugar and London's White Sugar contracts saw similar rises by about 2.40%.… Read More

3 hours ago
  • Technology

HMD Global Shifts Nokia Production to Europe, Targets 5G

Quick Look: HMD Global shifts Nokia's production to Europe, focusing on 5G tech. New Nokia… Read More

4 hours ago
  • Cryptocurrencies

LocalMonero to Close: A Blow to the No-KYC Monero Ecosystem

Quick Look: LocalMonero is set to close by November 7, 2024, due to undisclosed factors… Read More

7 hours ago
  • Cryptocurrencies

Robinhood Challenges SEC’s Claim on Crypto Trading

Quick Look: Robinhood received a Wells notice from the SEC on May 4, 2023, regarding… Read More

7 hours ago